Research spanning three decades has mapped how this 15-amino acid peptide interacts with vascular tissue, revealing mechanisms that extend well beyond its better-known healing properties
doi: 10.1002/biof.5520100402 252 SelvarajB
where it appears in clinical or off-label use, it does so through compounding channels that federal regulators have since restricted (see legal status below)
Swiss researcher Guido Monnier first isolated it in 1974 from the blood of sleeping rabbits
When an H1N1 strain with a haemagglutinin shift emerged in the 2009 H1N1 pandemic, some epidemiological studies linked a greater incidence of medically treated illness to previous vaccination against influenza, whereas others did not 38,39,40,41
Corti A, Dominici S, Piaggi S, Belcastro E, Chiu M, Taurino G, et al